Advising Jagex on its sale

Long-standing client Jagex, one of the UK’s largest video game developers and publishers, on its sale to The Carlyle Group. The transaction positions Jagex for continued growth in the global gaming market, building upon its existing 300 million players accounts and $1bn RuneScape franchise.

Advising gene therapy company AlveoGene on its complex spinout and launch investment

We have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.

Apollo Therapeutics closes $226.5 million series C financing

We advised Apollo Therapeutics in their USD226.5 million series C fundraising. Apollo aims to advance pipeline programs through clinical development and further fund the company’s drug discovery and development activities based on breakthroughs in basic medical research made at its partner institutions, which include The Institute of Cancer Research.